GENTAUR Contact Gentaur

Up

GENTAUR Survey

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com

GENTAUR Ltd. GB111298832
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com

GENTAUR France SARL FR63484237888
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com

GENTAUR GmbH
DE815175831
Marienbongard 20
52062 Aachen Deutschland
Tel tech support 0241 56 00 99 68  Frau Karolina Eland
de@gentaur.com
or  Tel 0241 95 78 94 78 Mr Tryan Ilkov
Tel logistics 0241 40 08 90 86 Annick Verdeyen
Fax 0241 55  91 05 36
Bankleitzahl 39050000
IBAN DE8839050000107569353
Handelsregister Aachen HR B 16058
Steuernummer 201/5961/3925
de@gentaur.com

GENTAUR Nederland BV NL850396268B01
Kuiper 1
5521 DG Eersel Nederland
KVK nummer 52327027
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

GENTAUR Poland Sp. z o.o. PL2040002710
Ulica Ogarna 15/19B m2
80-826 GDANSK Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              
(TEL production Warsaw 0223 98 82 21)
poland@gentaur.com

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Phone: (408) 472-2934
Fax: (408) 416-3994
before 9 a.m. Phone (718)513-2983
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave
San Jose, CA 95123

anti-mouse IL-12, mab 103-M23 500 250 57 anti-mouse Lyve-1, pab 103-PABi50 50 210 66 anti-mouse IL-12, pab 103-P19 100 270 56 human MCP-1 (MCAF) 100-065 20 210 67 human IL-12p40 100-311 10 210 57 anti-human MCP-1, mab 101-M12 500 250 67 mouse IL-12p40 M10-070 10 210 57 anti-human MCP-1/MCAF, pab 102-P55 100 270 67 human IL-13 100-052 10 210 57 rat MCP-1 (MCAF) R20-010 10 210 67 anti-human IL-13, pab 102-P43 100 270 57 anti-rat MCP-1/MCAF, pab 104-P08 100 270 67 mouse IL-13 M10-071 10 210 57 human MCP-2 100-066 10 210 67 anti-mouse IL-13, pab 103-P60 100 270 57 anti-human MCP-2, mab 101-M75 500 250 67 rat IL-13 R20-031 10 210 57 anti-human MCP-2, pab 102-P56 100 270 67 human IL-15 100-053 10 210 58 mouse MCP-2 M10-075 20 210 67 anti-human IL-15, mab 101-M10 100 270 58 human MCP-3 100-067 10 210 67 anti-human IL-15, pab 102-P44 100 270 58 anti-human MCP-3, mab 101-M13 500 250 67 mouse IL-15 M10-022 10 210 58 anti-human MCP-3, pab 102-P177 100 270 67 rat IL-15 R20-032 10 210 58 anti-human MCP-3, pab 102-P57 100 270 67 human IL-16 100-054 10 210 58 mouse MCP-3 M10-031 10 210 67 anti-human a-h IL-16 102-P45 100 270 58 anti-mouse MCP-3, pab 103-P27 100 270 67 mouse IL-16 (130aa) M10-083 10 210 58 human MCP-4 100-068 10 210 67 human IL-17A 100-055 25 210 59 anti-human MCP-4, mab 101-M76 500 250 67 anti-human IL-17A, pab 102-P46 100 270 59 anti-human MCP-4, pab 102-P58 100 270 67 anti-human IL-17A, pab 102-P162 100 270 59 anti-human MCP-4, pab 102-P180 100 270 67 human IL-17B 100-225 25 210 59 mouse MCP-5 M10-032 20 210 67 human IL-17D 100-226 25 210 59 anti-mouse MCP-5, pab 103-P28 100 270 67 human IL-17E 100-227 10 210 59 human M-CSF 100-064S 2 55 66 anti-human IL-17E, pab 102-P163 100 270 60 human M-CSF 100-064 10 135 66 human IL-17F 100-228 10 210 60 anti-human M-CSF, pab 102-P60 100 270 66 anti-human IL-18BP, pab 102-P47 100 270 60 mouse M-CSF M10-078 10 210 66 human IL-19 100-229 10 210 60 anti-mouse M-CSF, pab 103-P63 100 270 66 human IL-20 100-230 10 210 60 human MDC (67 aa) 100-069 20 210 68 anti-human IL-20, pab 102-P165 100 270 61 human MDC (69 aa) 100-070 20 210 68 anti-human IL-22, pab 102-P166 100 270 61 anti-human MDC, mab 101-M77 500 250 68 mouse IL-22 M10-072 10 210 61 anti-human MDC, pab 102-P61 100 270 68 human IL-31 100-232 10 210 61 mouse MDC M10-033 20 210 68 mouse IL-31 M10-073 10 210 61 anti-mouse MDC, pab 103-P66 100 270 68 human IP-10 100-057 25 210 61 human MEC 100-246 20 210 68 anti-human IP-10, pab 102-P48 100 270 62 mouse MEC M10-090 20 210 68 mouse IP-10 M10-025 25 210 61 anti-mouse MECA32, mab 103-M42 100 230 68 anti-mouse IP-10, pab 103-P21 100 270 62 human MIA 100-247 20 210 69 human I-TAC 100-058 20 210 62 human Midkine 100-071 20 210 69 anti-human I-TAC, pab 102-P49 100 270 62 anti-human Midkine, pab 102-P183 100 270 69 mouse I-TAC/CXCL11 M10-086 20 210 62 human MIG 100-072 20 210 70 mouse JE (MCP-1) M10-026 100 210 67 anti-human MIG, mab 101-M78 500 250 70 anti-mouse JE (MCP-1), pab 103-P22 20 270 67 anti-human MIG, pab 102-P62 100 270 70 mouse KC (CXCL1) M10-027 20 210 41 mouse MIG M10-034 20 210 70 anti-mouse KC (CXCL1), pab 103-P23 100 270 41 human MIP-1 alpha 100-073 20 210 70 human LAG-1 100-234 20 210 62 anti-human MIP-1 alpha, mab 101-M14 500 250 71 human LD78beta/CCL3L1 100-235 20 210 63 anti-human MIP-1 alpha, pab 102-P63 100 270 71 anti-human LD78-beta, pab 102-P169 100 270 63 mouse MIP-1 alpha M10-035 10 210 70 human LEC/NCC-4 100-060 20 210 63 anti-mouse MIP-1 alpha, pab 103-P29 100 270 71 anti-human LEC, mab 101-M73 500 250 63 rat MIP-1 alpha R20-011 20 210 70
anti-rat MIP-1 alpha 104-P09 100 270 71 anti-human PlGF (nat), pab 102-PA04AG 50 180 82
human MIP-1 beta 100-074 10 210 71 anti-human Podoplanin, mab 101-M40 100 250 83
anti-human MIP-1 beta, pab 102-P64 100 270 71 anti-human Podoplanin Biotin, mab 101-MBi40 50 250 83
mouse MIP-1 beta M10-077 10 210 71 anti-human Podoplanin, pab 102-PA40S 100 175 83
rat MIP-1 beta R20-035 20 210 71 anti-human Podoplanin, pab 102-PA40 200 290 83
mouse MIP-1 gamma M10-036 20 210 72 anti-human Podoplanin, mab 103-M40 100 250 83
anti-mouse MIP-1 gamma, pab 103-P30 100 270 72 anti-human Podoplanin Biotin, mab 103-MBi40 50 250 83
mouse MIP-2 (CXCL2) M10-037 20 210 72 human Prokineticin-2 100-272 20 210 83
anti-mouse MIP-2/CXCL2, pab 103-P31 100 270 72 human Prolactin 100-273 20 210 84
human MIP-3 100-075 20 210 73 human Prox-1 (fragment) 300-052 5 70 84
anti-human MIP-3, pab 102-P66 100 270 73 anti-human Prox-1 (E,W,IF), pab 102-PA32S 100 150 84
anti-human MIP-3, pab 102-P66G 100 270 73 anti-human Prox-1 (E,W,IF), pab 102-PA32 200 225 84
human MIP-3 alpha 100-078 20 210 73 anti-human Prox-1 (E,W,IF), pab 102-PA32AG 50 175 84
anti-human MIP-3 alpha, mab 101-M79 500 250 73 anti-human Prox-1 (IHC), pab 102-PA30S 100 175 84
anti-human MIP-3 alpha, pab 102-P67 100 270 73 anti-human Prox-1 (IHC), pab 102-PA30 200 290 84
mouse MIP-3 alpha M10-100 20 210 73 human PTHrP 100-275 50 210 85
human MIP-3 beta 100-079 20 210 74 human sRANK receptor 100-117 20 210 86
anti-human MIP-3 beta, mab 101-M80 500 250 74 anti-human RANK receptor, pab 102-P206 100 270 86
anti-human MIP-3 beta, pab 102-P68 100 270 74 human sRANKL 100-276 10 210 85
mouse MIP-3 beta M10-079 20 210 74 anti-human sRANKL, mab 101-M82 500 250 85
anti-human MIP-4, pab 102-P69 100 270 74 anti-human sRANKL, pab 102-P204 100 270 85
human MIP-4 (PARC) 100-080 10 210 74 anti-human sRANKL, pab 102-P205 100 270 85
human MIP-5 100-081 25 210 75 mouse sRANKL M10-080 10 210 85
anti-human MIP-5, pab 102-P70 100 270 75 anti-mouse sRANKL, pab 103-P71 100 270 85
human Myostatin 100-255 10 210 75 human RANTES 100-095 20 210 86
human NAP-2 100-082 10 210 75 anti-human RANTES, mab 101-M16 500 250 86
anti-human NAP-2, mab 101-M81 500 250 76 anti-human RANTES, pab 102-P80 100 270 86
anti-human NAP-2, pab 102-P71 100 270 76 anti-mouse RANTES, pab 103-P32 100 270 86
anti-human NAP-2, pab 102-P191 100 270 76 anti-rat RANTES, pab 104-P10 100 270 86
human Neurturin 100-083 10 210 76 mouse RANTES M10-038 20 210 86
anti-human Neurturin, pab 102-P72 100 270 76 rat RANTES R20-012 20 210 86
human NGF-beta 100-084 20 210 76 human RELM alpha 100-279 20 210 87
anti-human NGF-beta, pab 102-P73 100 270 76 mouse RELM alpha M10-081 20 210 87
human NNT-1/BCSF-3 100-259 10 210 77 mouse RELM beta M10-082 20 210 87
human NOGGIN 100-260 20 210 77 anti-mouse RELM beta, pab 103-P50 100 270 87
human NP-1 100-085 20 210 77 human Resistin 100-280 25 210 87
anti-human NP-1, pab 102-P194 100 270 77 anti-human Resistin, pab 102-P92 100 270 88
human NT-3 100-086 10 210 78 mouse Resistin M10-084 25 210 87
anti-human NT-3, pab 102-P74 100 270 78 anti-mouse Resistin, pab 103-P51 100 270 88
anti-human NT-3, pab 102-P196 100 270 78 human SCF 100-097S 2 55 88
human NT-4 100-087 10 210 78 human SCF 100-097 10 135 88
anti-human NT-4, mab 101-M15 500 250 78 human SCF 100-097-SC 50 395 88
anti-human NT-4, pab 102-P75 100 270 78 human SCF 400-013S 2 65 88
anti-human NT-4, pab 102-P198 100 270 78 human SCF 400-013 5 120 88
human Oncostatin M 100-088 10 210 79 human SCF 400-014 20 320 88
anti-human Oncostain M, pab 102-P76 100 270 79 human SCF 400-014-SC 50 425 88
human Osteoprotegerin (OPG) 100-089 50 210 79 anti-human SCF, mab 101-M83 500 250 89
anti-human OPG, pab 102-P200 100 270 79 anti-human SCF, pab 102-P81 100 270 89
human PDGF-AA 200-051S 2 55 80 anti-human SCF, pab 102-P81G 100 270 89
human PDGF-AA 200-051 5 90 80 mouse SCF M10-039 10 210 88
human PDGF-AA 200-052 20 350 80 anti-mouse SCF, pab 103-P33 100 270 89
anti-human PDGF-AA, pab 102-P77 100 270 80 rat SCF R20-040 10 210 88
human PDGF-AB 200-053S 2 55 80 anti-rat SCF, pab 104-P30 100 270 89
human PDGF-AB 200-053 5 90 80 human SCGF-alpha 100-098 10 210 89
human PDGF-AB 200-054 20 350 80 anti-human SCGF-alpha, pab 102-P93 100 270 89
human PDGF-BB 200-055S 2 55 80 human SCGF-beta 100-096 10 210 89
human PDGF-BB 200-055 5 90 80 human SDF-1 alpha 100-099 10 210 89
human PDGF-BB 200-056 20 350 80 anti-human SDF-1 alpha, pab 102-P82 100 270 90
anti-human PDGF-BB, pab 102-P78 100 270 80 mouse SDF-1 alpha M10-040 10 210 89
human Persephin (PSP) 100-120 20 210 80 anti-mouse SDF-1 alpha, pab 103-P34 100 270 90
human PF-4 100-093 20 210 81 human SDF-1 beta 100-100 10 210 90
anti-human PF-4, pab 102-P79 100 270 81 anti-human SDF-1 beta, pab 102-P83 100 270 90
human Pleiotrophin 100-094 20 210 81 mouse SDF-1 beta M10-085 10 210 90
human PIGF-1 300-015S 2 80 81 mouse SF20 M10-092 10 210 90
human PIGF-1 300-015 5 160 81 human TACI 100-285 20 210 91
human PIGF-1 300-016 20 490 81 anti-human TACI, pab 102-P94 100 270 91
human PIGF-1/His 300-017S 2 70 81 human TARC 100-101 20 210 91
human PIGF-1/His 300-017 5 130 81 anti-human TARC, pab 102-P84 100 270 91
human PIGF-1/His 300-018 20 425 81 human TECK 100-102 20 210 92
human PIGF-2 300-019S 2 80 82 anti-human TECK, mab 101-M84 500 250 92
human PIGF-2 300-019 5 160 82 anti-human TECK, pab 102-P85 100 270 92
human PIGF-2 300-020 20 490 82 human TFF-1 100-288 20 210 92
anti-human PlGF, apb 102-PA01S 100 150 82 human TFF-2 100-289 20 210 92
anti-human PlGF, pab 102-PA01 200 225 82 human TGF-alpha 100-103 100 210 93
anti-human PlGF (nat), pab 102-PA04S 100 150 82 anti-human TGF-alpha, pab 102-P86 100 270 93

human TGF-beta1 300-023 5 210 93 anti-human VEGF-A, pab 102-PA02 200 225 104
anti-mouse TGF-beta1, mab 101-M85 100 250 93 anti-human VEGF-A, pab 102-PA03S 100 150 104
human TGF-beta2 100-105 5 210 94 anti-human VEGF-A, pab 102-PA03 200 225 104
human TGF-beta3 100-107 5 210 94 anti-mouse VEGF-A, pab 103-PA03S 100 150 104
human sTIE-1/Fc Chimera SFC-011 20 100 94 anti-mouse VEGF-A, pab 103-PA03 200 150 104
human sTIE-1/Fc Chimera SFC-012 100 285 94 anti-mouse VEGF-A, pab 103-PA03AG 50 175 104
anti-human TIE-1 (#6F12), mab 101-M48 100 230 94 anti-mouse VEGF-A, pab 103-P36 100 270 104
anti-human TIE-1 (#6F12) Biotin, mab 101-MBi48 50 230 94 anti-human VEGF-A (#3), mab 101-M59 100 230 104
anti-human TIE-1 (#8C9), mab 101-M46 100 230 94 anti-human VEGF-A (#3C5), mab 101-M56 100 230 104
mouse sTIE-1/Fc Chimera SFC-031 20 100 94 anti-human VEGF-A (#7G7), mab 101-M58 100 230 104
mouse sTIE-1/Fc Chimera SFC-032 100 285 94 human VEGF-A BIOLISA (active) DA-066 96-well 395 103
human sTIE-2/Fc Chimera SFC-013 20 100 94 human VEGF-A ELISA (total) DA-068 96-well 395 102
human sTIE-2/Fc Chimera SFC-014 100 285 94 mouse VEGF-A ELISA (total) DA-072 96-well 375 103
anti-human TIE-2 (#tek2), mab 101-M50 100 230 95 rat VEGF-C R20-014 5 95 104
anti-human TIE-2 (#tek2) Biotin, mab 101-MBi50 50 230 95 rat VEGF-C R20-015 20 220 104
anti-human TIE-2 (#tek9), mab 101-M52 100 230 95 anti-rat VEGF-C, pab 104-PA10S 100 150 106
anti-human TIE-2 (#tek9) Biotin, mab 101-MBi52 50 230 95 anti-rat VEGF-C, pab 104-PA10 200 225 106
anti-human TIE-2 (#tek16), mab 101-M54 100 230 95 human VEGF-C ELISA (total) DA-070 96-well 395 105
anti-human TIE-2 (#tek16) Biotin, mab 101-MBi54 50 230 95 rat VEGF-C ELISA (total) DA-074 96-well 395 105
mouse sTIE-2/Fc Chimera SFC-033 20 100 95 rat VEGF-C152S R20-016 5 90 105
mouse sTIE-2/Fc Chimera SFC-034 100 285 95 rat VEGF-C152S R20-017 20 195 105
human TL-1A 100-294 20 210 95 anti-rat VEGF-D, pab 104-PA12S 100 150 106
human TNF-alpha 300-027 10 55 96 anti-rat VEGF-D, pab 104-PA12 200 225 106
human TNF-alpha 300-028 50 135 96 orf-virus VEGF-E 300-044S 2 80 106
anti-human TNF-alpha, mab 101-M17 500 250 96 orf-virus VEGF-E 300-044 5 160 106
anti-human TNF-alpha, pab 102-P87 100 270 96 orf-virus VEGF-E 300-045 20 490 106
mouse TNF-alpha M10-041 20 210 96 orf-virus HB-VEGF-E 300-046S 5 160 107
anti-mouse TNF-alpha, pab 103-P35 100 270 96 orf-virus HB-VEGF-E 300-046 20 490 107
anti-mouse TNF-alpha, pab 103-P35G 100 270 96 human sVEGFR-1/Flt-1 (native) S01-009 5 50 107
rat TNF-alpha R20-013 20 210 96 human sVEGFR-1/Flt-1 (native) S01-010 20 140 107
anti-rat TNF-alpha, pab 104-P11 100 270 96 human sVEGFR.1/Flt-1 (D5) S01-011 5 50 107
human sTNF receptor type I 100-118 20 210 97 human sVEGFR.1/Flt-1 (D5) S01-012 20 140 107
anti-human TNF receptor type I, pab 102-P95 100 270 97 human sVEGFR.1/Flt-1 (D4) S01-013 5 125 108
human sTNF receptor type II 100-119 20 210 97 human sVEGFR.1/Flt-1 (D4) S01-014 20 240 108
anti-human TNF receptor type II, pab 102-P96 100 270 97 human sVEGFR.1/Flt-1 (D3) S01-015 5 125 108
human TNF-beta 100-108 20 210 96 human sVEGFR.1/Flt-1 (D3) S01-016 20 240 108
human TNF-beta 100-297 20 210 96 human sVEGFR-1(D7)-Fc Chimera SFC-005 10 75 108
anti-human TNF-beta, pab 102-P88 100 270 97 human sVEGFR-1(D7)-Fc Chimera SFC-006 50 235 108
human TPO 100-109S 2 55 98 anti-human VEGFR-1/Flt-1 (#EWC), mab 101-M24 100 250 109
human TPO 100-109 10 135 98 anti-human VEGFR-1/Flt-1 (#EIC), mab 101-M26 100 250 109
human TPO 100-109-SC 50 395 98 anti-human VEGFR-1/Flt-1 (#EWF), mab 101-M28 100 230 109
anti-human TPO, pab 102-P89 100 270 98 anti-human VEGFR-1 (#EWF), Biotin, mab 101-MBi28 50 230 109
mouse TPO M10-087 10 270 98 anti-human VEGFR-1/Flt-1 (#EWI), mab 101-M30 100 230 109
human sTRAIL R-1/DR4 S01-035 50 210 99 anti-human VEGFR-1/Flt-1, pab 102-PA20S 100 150 109
human sTRAIL R-2/DR5 S01-036 50 210 99 anti-human VEGFR-1/Flt-1, pab 102-PA20 200 225 109
human sTRAIL/Apo2L 100-301 50 210 98 human VEGFR-1 ELISA (total) DA-064 96-well 395 109
anti-human TRAIL/Apo2L, mab 101-M86 500 250 98 human sVEGFR-2/KDR (D7) S01-001 5 50 110
anti-human TRAIL/Apo2L, pab 102-P97 100 270 98 human sVEGFR-2/KDR (D7) S01-002 20 300 110
human TSLP 100-304 10 210 99 human sVEGFR-2/KDR-Fc Chimera SFC-007 10 75 110
human TWEAK 100-111 50 210 99 human sVEGFR-2/KDR-Fc Chimera SFC-008 50 235 110
anti-human TWEAK, pab 102-P90 100 270 100 anti-human VEGFR-2/KDR (#3), mab 101-M32 100 230 111
human sTWEAK receptor S01-037 25 210 100 anti-human VEGFR-2 (#3) Biotin, mab 101-MBi32 50 230 111
anti-human TWEAK receptor, pab 102-P98 100 270 100 anti-human VEGFR-2/KDR (#4), mab 101-M34 100 230 111
human VEGF 121 300-031S 2 80 100 anti-human VEGFR-2/KDR (#EIC), mab 101-M20 100 250 111
human VEGF 121 300-031 5 160 100 anti-human VEGFR-2 (#EIC) Biotin, mab 101-MBi20 50 250 111
human VEGF 121 300-032 20 490 100 anti-human VEGFR-2/KDR (#EWC), mab 101-M22 100 250 111
human VEGF 121 300-071S 2 70 100 anti-human VEGFR-2/KDR, pab 102-PA18 200 195 110
human VEGF 121 300-071 5 120 100 anti-human VEGFR-2/KDR, pab 102-PA19S 100 150 110
human VEGF 121 300-072 20 350 100 anti-human VEGFR-2/KDR, pab 102-PA19 200 225 110
human VEGF 145 300-033S 2 70 101 anti-human VEGFR-2/KDR, pab 102-PA19AG 50 175 110
human VEGF 145 300-033 5 130 101 anti-human VEGFR-2/sc-Fv, single chain 500-001 100 250 111
human VEGF 145 300-034 20 300 101 human sVEGFR-3/FLT-4 S01-017 10 140 112
mouse VEGF164 M30-001S 2 70 101 human sVEGFR-3/FLT-4 S01-018 50 300 112
mouse VEGF164 M30-001 5 130 101 human sVEGFR-3/Fc Chimera SFC-009 10 95 112
mouse VEGF164 M30-002 20 300 101 human sVEGFR-3/Fc Chimera SFC-010 50 265 112
mouse VEGF164 M10-043 10 210 101 anti-human VEGFR-3/FLT-4, pab 102-PA22AG 100 250 112
human VEGF 165 300-035S 2 70 102 anti-human VEGFR-3/FLT-4, pab 102-PA23S 100 150 112
human VEGF 165 300-035 5 130 102 anti-human VEGFR-3/FLT-4, pab 102-PA23 200 225 112
human VEGF 165 300-036 20 300 102 anti-human VEGFR-3/FLT-4, pab 102-PA23AG 50 175 112
human VEGF 165 300-075S 2 60 102 anti-human VEGFR-3/FLT-4, mab 101-M36 100 250 112
human VEGF 165 300-075 5 100 102
human VEGF 165 300-076 20 260 102
anti-human VEGF-A, pab 102-P91 100 270 104
anti-human VEGF-A, pab 102-P91G 100 270 104
anti-human VEGF-A, pab 102-PA02S 100 150 104

Home Up

Send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 12/18/15